PHARMACEUTICAL COMPOSITION COMPRISING (1R,4R)-6-FLUORO-N,N-DIMET HYL-4-PHENYL-4,9-DIHYDRO-3H-SPIRO[CYCLOHEXANE-1,1-PYRANO [3,4,B]INDOL]-4-AMINE AND A GABAPENTINOID.
The invention relates to a pharmaceutical composition comprising a first pharmacologically active ingredient selected from (1r,4r)-6-fluoro-N,N-dimethyl-4-phenyl-4,9-dihydro-3H-spiro [cyclohexane-1,1-pyrano[3,4,b]indol]-4-amine and the physiologically acceptable salts thereof, and a second pharmacologically active ingredient selected from gabapentinoids and the physiologically acceptable salts thereof.La presente invención se relaciona con una composición farmacéutica que comprende un primer ingrediente farmacológicamente activo seleccionado de (1r,4r)-6´-fluoro-N,N-di metil-4-fenil-4´,9´-dihidro-3´H-espiro[ciclohexan-1,1´-pirano[3,4 ,b]indol]-4-amina y las sales fisiológicamente aceptables de la misma y un segundo ingrediente farmacológicamente activo seleccionado de gabapentinoides y las sales fisiológicamente aceptables de los mismos.
